RU2642287C2 - Химерная частица hpv - Google Patents
Химерная частица hpv Download PDFInfo
- Publication number
- RU2642287C2 RU2642287C2 RU2014126587A RU2014126587A RU2642287C2 RU 2642287 C2 RU2642287 C2 RU 2642287C2 RU 2014126587 A RU2014126587 A RU 2014126587A RU 2014126587 A RU2014126587 A RU 2014126587A RU 2642287 C2 RU2642287 C2 RU 2642287C2
- Authority
- RU
- Russia
- Prior art keywords
- hpv
- chimeric
- polypeptide
- vlp
- seq
- Prior art date
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/295—Polyvalent viral antigens; Mixtures of viral and bacterial antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C07K14/01—DNA viruses
- C07K14/025—Papovaviridae, e.g. papillomavirus, polyomavirus, SV40, BK virus, JC virus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- C12N7/04—Inactivation or attenuation; Producing viral sub-units
- C12N7/045—Pseudoviral particles; Non infectious pseudovirions, e.g. genetically engineered
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5258—Virus-like particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
- A61K2039/575—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20023—Virus like particles [VLP]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
- Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ZA2011/08841 | 2011-12-01 | ||
| ZA201108841 | 2011-12-01 | ||
| PCT/IB2012/056912 WO2013080187A1 (en) | 2011-12-01 | 2012-12-03 | Hpv chimaeric particle |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU2014126587A RU2014126587A (ru) | 2016-01-27 |
| RU2642287C2 true RU2642287C2 (ru) | 2018-01-24 |
Family
ID=48534756
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2014126587A RU2642287C2 (ru) | 2011-12-01 | 2012-12-03 | Химерная частица hpv |
Country Status (18)
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2806424C2 (ru) * | 2019-07-19 | 2023-10-31 | Синоселлтех Лтд. | Поливалентная иммуногенная композиция против папилломавируса человека |
| US12440549B2 (en) | 2019-07-19 | 2025-10-14 | Sinocelltech Ltd. | Polyvalent immunogenicity composition for human papillomavirus |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107252489A (zh) | 2009-04-13 | 2017-10-17 | 法国健康和医学研究院 | Hpv颗粒及其用途 |
| WO2013119877A1 (en) | 2012-02-07 | 2013-08-15 | Aura Biosciences, Inc. | Virion-derived nanospheres for selective delivery of therapeutic and diagnostic agents to cancer cells |
| WO2015042325A1 (en) | 2013-09-18 | 2015-03-26 | Aura Biosciences, Inc. | Virus-like particle conjugates for diagnosis and treatment of tumors |
| CN104531741B (zh) * | 2014-08-22 | 2016-08-24 | 天津康希诺生物技术有限公司 | 增强hpv抗原表位肽免疫原性的方法及类病毒颗粒、颗粒制备方法与应用 |
| CN105801704B (zh) * | 2014-12-31 | 2020-06-02 | 艾托金生物医药(苏州)有限公司 | 一种具有抗宫颈癌细胞活性的重组疫苗构建方法及应用 |
| ES2999358T3 (en) | 2015-08-18 | 2025-02-25 | Rakuten Medical Inc | Phthalocyanine dye conjugates and their storage |
| ES2992591T3 (en) | 2015-08-18 | 2024-12-16 | Rakuten Medical Inc | Compositions, combinations and related methods for photoimmunotherapy |
| KR20180095511A (ko) | 2015-10-30 | 2018-08-27 | 더 유나이티드 스테이츠 오브 어메리카, 애즈 리프리젠티드 바이 더 세크러테리, 디파트먼트 오브 헬쓰 앤드 휴먼 서비씨즈 | 표적화된 암 요법 |
| JP2020515629A (ja) | 2017-04-04 | 2020-05-28 | アヴィディア テクノロジーズ, インコーポレイテッド | 免疫応答を誘導するためのペプチドベースのワクチン、それらの製造方法および使用 |
| AU2018251788B2 (en) | 2017-04-12 | 2025-04-10 | Aura Biosciences, Inc. | Targeted combination therapy |
| CN110891602A (zh) | 2017-06-23 | 2020-03-17 | 帕多瓦有限责任公司 | 嵌合病毒样颗粒以及其作为免疫反应的抗原特异性重定向剂的用途 |
| JP7641005B2 (ja) | 2018-12-27 | 2025-03-06 | ヴェリミューン インコーポレイテッド | コンジュゲート型ウイルス様粒子および抗腫瘍免疫リダイレクタとしてのその使用 |
| US12704501B2 (en) | 2019-03-29 | 2026-08-11 | Rakuten Medical, Inc. | Methods for photoimmunotherapy and related biomarkers |
| WO2021161179A1 (en) * | 2020-02-10 | 2021-08-19 | University Of Cape Town | Plant produced bovine papillomavirus virus-like particles and pseudovirions |
| MX2023004465A (es) | 2020-10-19 | 2023-06-19 | Verimmune Inc | Composiciones basadas en virus y métodos para redirigir respuestas inmunitarias preexistentes mediante su uso para el tratamiento del cáncer. |
| AU2023367780A1 (en) | 2022-10-25 | 2025-03-27 | Barinthus Biotherapeutics North America, Inc. | Self-assembling nanoparticles |
| KR102821363B1 (ko) | 2023-02-06 | 2025-06-13 | 영산대학교산학협력단 | 드론에 장착된 라이다 센서를 기초로 하는 수심 측량 시스템 |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020016372A1 (en) * | 2000-07-31 | 2002-02-07 | Allison Anthony Clifford | Method for preventing and treating alzheimer's disease and brain damage associated with cardiov ascular disease and head injury |
| RU2206608C2 (ru) * | 1994-05-16 | 2003-06-20 | Мерк Энд Ко., Инк. | Папилломавирусные вакцины |
| CA2486450A1 (en) * | 2002-05-17 | 2003-11-27 | University Of Cape Town | Chimaeric human papillomavirus 16 l1 virus-like particles and method for preparing the particles |
| WO2010118424A2 (en) * | 2009-04-10 | 2010-10-14 | The Johns Hopkins University | Papillomavirus-like particles (vlp) as broad spectrum human papillomavirus (hpv) vaccines |
| WO2010149752A2 (en) * | 2009-06-25 | 2010-12-29 | Glaxosmithline Biologicals S.A. | Novel compositions |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1105466B1 (en) | 1998-08-14 | 2006-04-26 | Merck & Co., Inc. | Process for purifying human papillomavirus virus-like particles |
| WO2003068804A2 (en) | 2002-02-14 | 2003-08-21 | Novavax, Inc. | Novel insect cell line |
| CN101166827B (zh) | 2005-04-29 | 2013-09-04 | 开普敦大学 | 在植物中表达蛋白质 |
| US9566323B2 (en) | 2009-06-19 | 2017-02-14 | Eyegene Inc. | Vaccine for cervical cancer |
| WO2011077371A1 (en) * | 2009-12-22 | 2011-06-30 | University Of Cape Town | Method for enhancing the expression of hpv l1 |
-
2012
- 2012-12-03 CN CN201280052968.8A patent/CN103890177B/zh not_active Expired - Fee Related
- 2012-12-03 SG SG11201401579UA patent/SG11201401579UA/en unknown
- 2012-12-03 CA CA2850293A patent/CA2850293C/en not_active Expired - Fee Related
- 2012-12-03 EP EP12853360.1A patent/EP2785842A4/en not_active Withdrawn
- 2012-12-03 BR BR112014012491A patent/BR112014012491A2/pt not_active IP Right Cessation
- 2012-12-03 HK HK14112143.5A patent/HK1198703A1/xx unknown
- 2012-12-03 JP JP2014544038A patent/JP6228922B2/ja not_active Expired - Fee Related
- 2012-12-03 IN IN3054DEN2014 patent/IN2014DN03054A/en unknown
- 2012-12-03 PH PH1/2014/500466A patent/PH12014500466A1/en unknown
- 2012-12-03 MX MX2014006520A patent/MX355352B/es active IP Right Grant
- 2012-12-03 RU RU2014126587A patent/RU2642287C2/ru not_active IP Right Cessation
- 2012-12-03 US US14/360,524 patent/US9771397B2/en not_active Expired - Fee Related
- 2012-12-03 KR KR1020147010686A patent/KR102013801B1/ko not_active Expired - Fee Related
- 2012-12-03 WO PCT/IB2012/056912 patent/WO2013080187A1/en not_active Ceased
- 2012-12-03 MY MYPI2014700894A patent/MY184076A/en unknown
- 2012-12-03 AU AU2012345443A patent/AU2012345443B2/en not_active Ceased
-
2014
- 2014-05-13 IL IL232584A patent/IL232584B/en active IP Right Grant
- 2014-05-16 ZA ZA2014/03557A patent/ZA201403557B/en unknown
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2206608C2 (ru) * | 1994-05-16 | 2003-06-20 | Мерк Энд Ко., Инк. | Папилломавирусные вакцины |
| US20020016372A1 (en) * | 2000-07-31 | 2002-02-07 | Allison Anthony Clifford | Method for preventing and treating alzheimer's disease and brain damage associated with cardiov ascular disease and head injury |
| CA2486450A1 (en) * | 2002-05-17 | 2003-11-27 | University Of Cape Town | Chimaeric human papillomavirus 16 l1 virus-like particles and method for preparing the particles |
| WO2010118424A2 (en) * | 2009-04-10 | 2010-10-14 | The Johns Hopkins University | Papillomavirus-like particles (vlp) as broad spectrum human papillomavirus (hpv) vaccines |
| WO2010149752A2 (en) * | 2009-06-25 | 2010-12-29 | Glaxosmithline Biologicals S.A. | Novel compositions |
Non-Patent Citations (3)
| Title |
|---|
| KIRNBAUER R. et al. Efficient Self-Assembly of Human Papillomavirus Type 16 LI and L1-L2 into Virus-Like Particles. JOURNAL OF VIROLOGY. 1993. V.67. No.12. P. 6929-6936. * |
| SCHELLENBACHER C. et al. Chimeric L1-L2 Virus-Like Particles as Potential Broad-Spectrum Human Papillomavirus Vaccines. JOURNAL OF VIROLOGY. 2009. V.83. No.19. P. 10085-10095;. * |
| VARSANI A. et al. Chimeric Human Papillomavirus Type 16 (HPV-16) L1 Particles Presenting the Common Neutralizing Epitope for the L2 Minor Capsid Protein of HPV-6 and HPV-16. JOURNAL OF VIROLOGY. 2003. V.77. No.15. P. 8386-8393;. * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2806424C2 (ru) * | 2019-07-19 | 2023-10-31 | Синоселлтех Лтд. | Поливалентная иммуногенная композиция против папилломавируса человека |
| US12440549B2 (en) | 2019-07-19 | 2025-10-14 | Sinocelltech Ltd. | Polyvalent immunogenicity composition for human papillomavirus |
Also Published As
| Publication number | Publication date |
|---|---|
| MY184076A (en) | 2021-03-17 |
| PH12014500466A1 (en) | 2022-05-11 |
| KR20140098061A (ko) | 2014-08-07 |
| US9771397B2 (en) | 2017-09-26 |
| ZA201403557B (en) | 2020-10-28 |
| HK1198703A1 (en) | 2015-05-29 |
| RU2014126587A (ru) | 2016-01-27 |
| MX355352B (es) | 2018-04-17 |
| EP2785842A1 (en) | 2014-10-08 |
| CN103890177A (zh) | 2014-06-25 |
| US20140377367A1 (en) | 2014-12-25 |
| EP2785842A4 (en) | 2015-11-25 |
| CA2850293A1 (en) | 2013-06-06 |
| IL232584B (en) | 2018-10-31 |
| IL232584A0 (en) | 2014-06-30 |
| CA2850293C (en) | 2019-10-08 |
| SG11201401579UA (en) | 2014-07-30 |
| BR112014012491A2 (pt) | 2017-06-06 |
| AU2012345443B2 (en) | 2017-10-26 |
| KR102013801B1 (ko) | 2019-08-23 |
| AU2012345443A1 (en) | 2014-04-17 |
| MX2014006520A (es) | 2014-11-21 |
| JP2015500229A (ja) | 2015-01-05 |
| JP6228922B2 (ja) | 2017-11-08 |
| IN2014DN03054A (cg-RX-API-DMAC7.html) | 2015-05-15 |
| WO2013080187A1 (en) | 2013-06-06 |
| NZ622595A (en) | 2016-04-29 |
| CN103890177B (zh) | 2016-03-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6228922B2 (ja) | Hpvキメラ粒子 | |
| Pineo et al. | Immunogenic assessment of plant‐produced human papillomavirus type 16 L1/L2 chimaeras | |
| Franconi et al. | Plant-derived human papillomavirus 16 E7 oncoprotein induces immune response and specific tumor protection | |
| Cerovska et al. | Transient expression of Human papillomavirus type 16 L2 epitope fused to N-and C-terminus of coat protein of Potato virus X in plants | |
| CN101487010B (zh) | 用毕赤酵母表达系统制备抗人乳头瘤病毒18型感染的疫苗的方法 | |
| Paz De la Rosa et al. | An HPV 16 L1-based chimeric human papilloma virus-like particles containing a string of epitopes produced in plants is able to elicit humoral and cytotoxic T-cell activity in mice | |
| JP2009524699A (ja) | 新規植物ウイルス粒子及びその不活性化の方法 | |
| JP2017528137A (ja) | 卓越した免疫学的特性を有する卓越したヒトパピローマウイルス抗原及びそれを含むワクチン | |
| Muthamilselvan et al. | Assembly of human papillomavirus 16 L1 protein in Nicotiana benthamiana chloroplasts into highly immunogenic virus-like particles | |
| WO2024099273A1 (zh) | 一种融合蛋白以及包含其的颗粒化的抗原 | |
| CN103667319B (zh) | 抗人乳头瘤病毒的三价疫苗及其制法和用途 | |
| Motavalli Khiavi et al. | A Dual‐Type L2 11‐88 Peptide from HPV Types 16/18 Formulated in Montanide ISA 720 Induced Strong and Balanced Th1/Th2 Immune Responses, Associated with High Titers of Broad Spectrum Cross‐Reactive Antibodies in Vaccinated Mice | |
| WO2011077371A1 (en) | Method for enhancing the expression of hpv l1 | |
| EP2172488A1 (en) | Material with immunogenicity | |
| WO2009076824A1 (zh) | 人乳头状瘤病毒主要衣壳蛋白l1基因及其用途 | |
| CN116925195B (zh) | 一种基于新型冠状病毒的mRNA疫苗 | |
| TW202120123A (zh) | 類屈公病毒顆粒疫苗及使用其之方法 | |
| US20060029612A1 (en) | Prevention and treatment of recurrent respiratory papillomatosis | |
| Meshcheryakova et al. | Cowpea mosaic virus chimeric particles bearing the ectodomain of matrix protein 2 (M2E) of the influenza A virus: production and characterization | |
| NZ622595B2 (en) | Hpv chimaeric particle | |
| WO2022003719A2 (en) | POLYPEPTIDE FRAGMENTS, IMMUNOGENIC COMPOSITION AGAINST SARS-CoV-2, AND IMPLEMENTATIONS THEREOF | |
| WO2008115631A2 (en) | Plant-produced compositions for treating papillomavirus infection and related methods | |
| US20250281594A1 (en) | Truncated recombinant l1 protein of human papillomavirus | |
| US20080160040A1 (en) | Plant-produced compositions for treating papillomavirus infection and related methods | |
| CN104845985A (zh) | 重组人乳头瘤病毒蛋白表达 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20201204 |